Key statistics
On Friday, Legend Biotech Corp (9LB:FRA) closed at 34.60, 16.11% above the 52 week low of 29.80 set on Jan 13, 2025.
52-week range
Open | 34.40 |
---|---|
High | 35.60 |
Low | 34.40 |
Bid | 34.60 |
Offer | 34.80 |
Previous close | 34.80 |
Average volume | 437.90 |
---|---|
Shares outstanding | 183.45m |
Free float | 180.37m |
P/E (TTM) | -- |
Market cap | 6.49bn USD |
EPS (TTM) | -1.91 USD |
Data delayed at least 15 minutes, as of Feb 14 2025 20:55 GMT.
More ▼
- Legend Biotech to Present at the 43rd Annual J.P. Morgan Healthcare Conference
- CARVYKTI® Significantly Improved Minimal Residual Disease Negativity Compared to Standard of Care for Patients with Relapsed or Refractory Multiple Myeloma
- Legend Biotech Reports Third Quarter 2024 Results and Recent Highlights
- Legend Biotech to Host Investor Event During the 66th American Society of Hematology (ASH) Annual Meeting and Exposition
- Legend Biotech to Unveil Minimal Residual Disease Data from Landmark CARTITUDE-4 Trial in Multiple Myeloma
- Legend Biotech Appoints Alan Bash as President of CARVYKTI®
- Legend Biotech to Host Investor Conference Call on Third Quarter 2024 Results
- Legend Biotech to Establish New, State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia
- CARVYKTI® is the First and Only Cell Therapy to Significantly Extend Overall Survival Compared to Standard of Care in Patients with Multiple Myeloma as Early as Second Line
- Legend Biotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
More ▼